RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Austar Lifesciences Stock

Austar Lifesciences ROCE 2024

Austar Lifesciences ROCE

-0.05

Ticker

6118.HK

ISIN

KYG0632L1023

In 2024, Austar Lifesciences's return on capital employed (ROCE) was -0.05, a -139.16% increase from the 0.14 ROCE in the previous year.

Austar Lifesciences Aktienanalyse

What does Austar Lifesciences do?

Austar Lifesciences Ltd is an Indian manufacturer of pharmaceutical products and medical devices. The company was founded in 2003 by Mr. Sudhir Taneja and is headquartered in the city of Mohali in the state of Punjab. Since its inception, the company has continuously evolved and is now a leading brand in the Indian healthcare market. Austar Lifesciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Austar Lifesciences's Return on Capital Employed (ROCE)

Austar Lifesciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Austar Lifesciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Austar Lifesciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Austar Lifesciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Austar Lifesciences stock

What is the ROCE (Return on Capital Employed) of Austar Lifesciences this year?

The ROCE of Austar Lifesciences is -0.05 undefined this year.

How has the ROCE (Return on Capital Employed) of Austar Lifesciences developed compared to the previous year?

The ROCE of Austar Lifesciences has increased by -139.16% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Austar Lifesciences?

A high Return on Capital Employed (ROCE) indicates that Austar Lifesciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Austar Lifesciences?

A low ROCE (Return on Capital Employed) can indicate that Austar Lifesciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Austar Lifesciences impact the company?

An increase in the ROCE of Austar Lifesciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Austar Lifesciences affect the company?

A decrease in ROCE of Austar Lifesciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Austar Lifesciences?

Some factors that can affect Austar Lifesciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Austar Lifesciences so important for investors?

The ROCE of Austar Lifesciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Austar Lifesciences take to improve the ROCE?

To improve the ROCE, Austar Lifesciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Austar Lifesciences pay?

Over the past 12 months, Austar Lifesciences paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 7.18 %. For the coming 12 months, Austar Lifesciences is expected to pay a dividend of 0 CNY.

What is the dividend yield of Austar Lifesciences?

The current dividend yield of Austar Lifesciences is 7.18 %.

When does Austar Lifesciences pay dividends?

Austar Lifesciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Austar Lifesciences?

Austar Lifesciences paid dividends every year for the past 0 years.

What is the dividend of Austar Lifesciences?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Austar Lifesciences located?

Austar Lifesciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Austar Lifesciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Austar Lifesciences from 6/26/2015 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 5/19/2015.

When did Austar Lifesciences pay the last dividend?

The last dividend was paid out on 6/26/2015.

What was the dividend of Austar Lifesciences in the year 2023?

In the year 2023, Austar Lifesciences distributed 0 CNY as dividends.

In which currency does Austar Lifesciences pay out the dividend?

The dividends of Austar Lifesciences are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Austar Lifesciences

Our stock analysis for Austar Lifesciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Austar Lifesciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.